Parallax Volatility Advisers
XPH icon

Parallax Volatility Advisers’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Parallax Volatility Advisers’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2
Closed – – 3639
2019
Q2 		$0 Hold
2
– – ﹤0.01% 3900
2019
Q1 		$0 Hold
2
– – ﹤0.01% 4223
2018
Q4 		$0 Hold
2
– – ﹤0.01% 4116
2018
Q3 		$0 Hold
2
– – ﹤0.01% 3749
2018
Q2 		$0 Hold
2
– – ﹤0.01% 3485
2018
Q1 		$0 Hold
2
– – ﹤0.01% 4458
2017
Q4 		$0 Hold
2
– – ﹤0.01% 5084
2017
Q3 		$0 Hold
2
– – ﹤0.01% 3461
2017
Q2 		$0 Hold
2
– – ﹤0.01% 4228
2017
Q1 		$0 Hold
2
– – ﹤0.01% 4809
2016
Q4 		$0 Hold
2
– – ﹤0.01% 4340
2016
Q3 		$0 Hold
2
– – ﹤0.01% 4101
2016
Q2 		$0 Hold
2
– – ﹤0.01% 3709
2016
Q1 		$0 Hold
2
– – ﹤0.01% 3869
2015
Q4 		$0 Hold
2
– – ﹤0.01% 4069
2015
Q3 		$0 Hold
2
– – ﹤0.01% 4353
2015
Q2 		$0 Hold
2
– – ﹤0.01% 5112
2015
Q1 		$0 Hold
2
– – ﹤0.01% 5708
2014
Q4 		$0 Buy
+2
New +$109 ﹤0.01% 6013

Other funds holding XPH

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Parallax Volatility Advisers's XPH Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2019, closing a stake of 2 shares.

Parallax Volatility Advisers first reported a position in XPH in Q4 2014 and held it in 19 quarters. The position peaked at $0 in Q2 2019. 60 funds tracked by Wall St. Rank hold XPH as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2019.
  • Parallax Volatility Advisers first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2014 and held it in 19 quarters.
  • Parallax Volatility Advisers's State Street SPDR S&P Pharmaceuticals ETF position peaked at $0 in Q2 2019.
  • 60 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.